Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ARMK | CTAS |
|---|---|---|
| Price | $54.46 | $194.95 |
| Change today | ▲ 1.70% | ▼ 0.06% |
| Market cap | $14.36B | $77.89B |
| Return, 3 months | -2.7% | +12.2% |
| Return, year to date | +48.8% | +4.4% |
| Return, 1 year | +43.6% | -3.3% |
| P/E (TTM) | 38.1 | 38.5 |
| P/B | 4.2 | 15.0 |
| P/E percentile vs own 5y | 57th | 44th |
| Dividend yield | 0.85% | 0.96% |
| Revenue growth (YoY, latest qtr) | +9.3% | +8.9% |
| Net profit growth (YoY) | +36.0% | +14.0% |
| Gross margin | 8.5% | 50.7% |
| Operating margin | 4.4% | 23.3% |
| Net margin | 1.9% | 17.7% |
| Return on equity | 11.8% | 40.6% |
| Analyst target vs. price | +27.0% | +13.4% |
| Analyst buy share | 92% | 75% |
| RSI (14) | 32 | 43 |
| 30-day volatility | 19.8% | 15.1% |
| Max drawdown, 1 year | -14.0% | -20.0% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
